- Drug Pipelines
- February 2018
- 12 Pages
Global
From €9934EUR$10,000USD£8,260GBP
- Drug Pipelines
- February 2018
- 19 Pages
Global
From €9934EUR$10,000USD£8,260GBP
- Drug Pipelines
- January 2018
- 20 Pages
Global
From €9934EUR$10,000USD£8,260GBP
- Report
- September 2023
- 180 Pages
Global
From €5911EUR$5,950USD£4,915GBP
- Report
- March 2022
- 300 Pages
Global
From €4967EUR$5,000USD£4,130GBP
- Report
- November 2023
- 250 Pages
Global
From €2434EUR$2,450USD£2,024GBP
- Report
- August 2023
- 230 Pages
Global
From €2434EUR$2,450USD£2,024GBP
- Report
- April 2023
- 275 Pages
Global
From €3964EUR$3,990USD£3,296GBP
- Report
- November 2023
- 150 Pages
Global
From €4818EUR$4,850USD£4,006GBP
- Report
- July 2022
- 50 Pages
China
From €3576EUR$3,600USD£2,974GBP
- Report
- January 2023
- 50 Pages
China
From €2980EUR$3,000USD£2,478GBP
- Report
- July 2021
- 50 Pages
China
From €2583EUR$2,600USD£2,148GBP
- Report
- July 2021
- 50 Pages
China
From €2583EUR$2,600USD£2,148GBP
- Report
- July 2021
- 50 Pages
China
From €2583EUR$2,600USD£2,148GBP
- Report
- August 2019
- 30 Pages
China
From €2186EUR$2,200USD£1,817GBP
- Report
- November 2018
- 30 Pages
China
From €2186EUR$2,200USD£1,817GBP
- Report
- November 2018
- 30 Pages
China
From €2186EUR$2,200USD£1,817GBP
- Report
- July 2018
- 30 Pages
China
From €2186EUR$2,200USD£1,817GBP
- Report
- August 2023
- 198 Pages
Global
From €3164EUR$3,185USD£2,631GBP
€4520EUR$4,550USD£3,758GBP
- Report
- February 2023
- 143 Pages
North America
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more